“Dr. Michael Chaglasian discusses the successful use of Monaco OCT in detecting glaucoma at ARVO 2024”

A recent study presented at the annual Association for Research in Vision and Ophthalmology meeting in Seattle, Washington, revealed promising findings in the detection of glaucoma using the new Monaco optical coherence tomography (OCT) combined with ultra widefield imaging from Optos. Dr. Michael Chaglasian, from the Illinois College of Optometry, shared the results of his research in a presentation titled “Detection of glaucoma with a novel widefield imaging device combined with OCT.”

The study included 33 glaucoma subjects with varying levels of severity, as well as a group of age-matched normal individuals. Using the Monaco device, researchers were able to identify key indicators for detecting glaucoma, such as vertical CD ratio, rim area, average retinal nerve fiber layer thickness, inferior RNFL thickness, and glaucoma ganglion cell complex.

The results of the study showed that the Monaco OCT combined with ultra widefield imaging was successful in detecting glaucoma in patients when compared to normal individuals. This new technology proves to be a valuable tool for optometrists and ophthalmologists in identifying glaucoma with a high level of accuracy similar to current OCT imaging techniques.

Moving forward, the researchers plan to expand the study to include a larger sample size to further validate the effectiveness of the Monaco OCT in detecting glaucoma. Dr. Chaglasian also disclosed that he conducts research work with Optos, the company behind the innovative imaging technology.

Overall, this study highlights the potential of the Monaco OCT combined with ultra widefield imaging as a reliable and effective tool for the detection of glaucoma, providing healthcare professionals with confidence in diagnosing this sight-threatening condition.